These findings suggest that matrine derivatives may suppress the proliferation and activation of MRC-5 cells via the TGF-β1/Smad signaling pathway, thereby altering the biological morphology of the cells and providing a potential therapeutic approach for pulmonary fibrosis (Li L. et al., 2019). The gene discussed is TGFB1; the disease is pulmonary fibrosis.